Adrenocortical carcinoma · NCT04358107
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
Retrospective Study of Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
- Status
- ACTIVE_NOT_RECRUITING (ClinicalTrials.gov)
- Phase
- observational
- Sponsor
- National Cancer Institute (NCI)
- Registry records
- CTGOV NCT04358107 (ACTIVE_NOT_RECRUITING)Registry last updated 2026-03-12
Eligibility, line by line
| Verdict | In plain words (machine summary) | Registry text, verbatim | If unmet |
|---|---|---|---|
| inclusion inclusion · other · confidence 0.30 | Patients enrolled on any of the studies listed below: 92-C-0268, 93-C-0200, 00-C-0044, 01-C-0129, 04-C-001, 09-C-0242, 08-C-0176, 10-C-0203, 13-C-0114, 14-C-0029 | "Patients enrolled on any of the studies listed below:" | |
| exclusion exclusion · consent · confidence 0.30 | Patients who opted out of future use of data on their prior studies will be excluded from this study. | "Patients who opted out of future use of data on their prior studies will be excluded from this study." |
Criteria extracted by claude-sonnet-5-5; 0 extracted quotes rejected for not matching the registry text.
Full eligibility text as the registry publishes it
* INCLUSION CRITERIA: * Patients enrolled on any of the studies listed below: * 92-C-0268, 93-C-0200, 00-C-0044, 01-C-0129, 04-C-001, 09-C-0242, 08-C-0176, 10-C-0203, 13-C-0114, 14-C-0029 EXCLUSION CRITERIA: -Patients who opted out of future use of data on their prior studies will be excluded from this study.
Routes in: how this trial is reached and paid for
US trials at ordinary hospitals: routine care is billed
In the US a sponsor funds the study drug and study-specific scans, but the routine care around them is billed to insurance. Without US cover that bill falls on you.
Cost is documented as the barrier that stops roughly 45 percent of US patients joining trials, before any question of being a non-resident. Eligibility on paper does not make a US site reachable. One email to the study coordinator asking what a non-resident without US insurance would be billed settles it either way.
Verify with: The study coordinator listed on the registry record
Ask first; potentially very high
Free patient navigation
myTomorrows (Amsterdam) provides medically trained, multilingual patient navigators who search ClinicalTrials.gov, EU CTIS and ISRCTN and can support a doctor through an expanded-access application. Free to patients and families.
A navigator keeps searching after any single page stops being current. Use it alongside this site, not instead of your oncologist.
Verify with: myTomorrows for patients
0
Sites (1)
United States
- National Cancer Institute (NCI), Bethesda